[{"id":"bb9b1fd6-07d2-4950-8e57-40864d118e0a","acronym":"","url":"https://clinicaltrials.gov/study/NCT04506567","created_at":"2021-01-18T21:36:26.540Z","updated_at":"2024-07-02T16:35:38.849Z","phase":"Phase 1/2","brief_title":"Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC","source_id_and_acronym":"NCT04506567","lead_sponsor":"Weill Medical College of Cornell University","biomarkers":" CYP17A1","pipe":"","alterations":" ","tags":["CYP17A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ac-225 rosopatamab tetraxetan (CONV01-α)"],"overall_status":"Recruiting","enrollment":" Enrollment 105","initiation":"Initiation: 08/18/2020","start_date":" 08/18/2020","primary_txt":" Primary completion: 06/30/2025","primary_completion_date":" 06/30/2025","study_txt":" Completion: 06/30/2027","study_completion_date":" 06/30/2027","last_update_posted":"2023-08-28"}]